View Older Stories

Dec 18, 2025 03:11PM RBC: 'We have just confirmed that a recent clinicaltrials.gov listing for a new drug called BIIB145'

Nov 16, 2025 03:00PM Where can biotech stocks go from here? RBC answers

Oct 12, 2025 03:00PM Biotech stocks: Q3 earnings preview

Oct 8, 2025 09:23AM Biogen (BIIB) PT Lowered to $217 at RBC Capital

Jul 10, 2025 10:41AM RBC Capital on Biogen (BIIB): 'Long-Term Vision Coming Together'

Jul 2, 2025 10:00AM These 30 global stocks offer tactical and structural upside, says RBC

Jun 30, 2025 07:51AM RBC says Lilly could blaze trail and Biogen could pull ahead in Alzheimer’s market

Jun 30, 2025 04:44AM RBC: "How LLY Could Blaze a Trail and BIIB Could Pull AHEAD In The Large, Overlooked Pre-Sx AD Mkt"

Apr 12, 2025 04:00AM Biotech sector Q1 earnings preview from RBC Capital Markets

Apr 3, 2025 08:57AM Biogen (BIIB) PT Lowered to $221 at RBC Capital

Feb 13, 2025 08:08AM Biogen (BIIB) PT Lowered to $225 at RBC Capital

Jan 7, 2025 09:07AM Biogen (BIIB) PT Lowered to $231 as RBC Capital Sees 'Attractive Entry Point for Shares'

Dec 19, 2024 11:16AM RBC Capital's Game Changers: 'Disruptive Forces in Biotech'

Oct 31, 2024 06:31AM Biogen (BIIB) PT Lowered to $260 at RBC Capital

Aug 2, 2024 06:24AM Biogen (BIIB) PT Raised to $292 at RBC Capital

Jul 26, 2024 10:10AM Biogen (BIIB) PT Lowered to $282 at RBC Capital

Jul 11, 2024 01:32PM Biogen: RBC says 'very likely' that Leqembi will be approved in Europe

Jul 11, 2024 06:37AM RBC Capital Reiterates Outperform Rating on Biogen (BIIB), very likely Leqembi will be approved in Europe

Jul 2, 2024 01:55PM Eli Lilly Alzheimer's drug approved by US FDA

Jun 26, 2024 03:25PM RBC Capital on Biogen (BIIB): 'We See An EU Approval In 3Q24 As Likely'

Jun 26, 2024 05:24AM RBC Capital Reiterates Outperform Rating on Biogen (BIIB)

Jun 7, 2024 09:14AM RBC Capital Reiterates Outperform Rating on Biogen (BIIB)

Jun 6, 2024 09:50AM RBC Capital Reiterates Outperform Rating on Biogen (BIIB)

Jun 5, 2024 06:11AM RBC Capital Reiterates Outperform Rating on Biogen (BIIB)

May 29, 2024 05:31AM RBC Capital Reiterates Outperform Rating on Biogen (BIIB)

Apr 25, 2024 06:39AM Biogen (BIIB) PT Lowered to $317 at RBC Capital

Jul 11, 2023 06:41AM Biogen (BIIB) PT Raised to $341 at RBC Capital following neurologist survey on donamenab

Apr 26, 2023 03:16PM RBC Capital on Biogen (BIIB): 'CMS Makes It Clear - Leqembi Will Be Broadly Reimbursed - Should Reduce Overhang'

Jan 10, 2023 09:50AM RBC Capital on Biogen (BIIB): 'FDA Summary Review Now Available; We Believe Suggests High Amenability For Future Full Leca Approval'

Jan 6, 2023 07:05AM Biogen (BIIB) gains ahead of lecanemab PDUFA

Jan 5, 2023 04:11PM RBC Capital on Biogen (BIIB): 'a very favorable stock setup'

Nov 28, 2022 10:05AM Biogen (BIIB) Stock Falls on Alzheimer's Drug Trial Death Reports

May 3, 2022 07:21AM Biogen CEO to step down; drugmaker pulls back on Alzheimer's drug Aduhelm

Mar 3, 2022 05:16AM RBC Capital Upgrades Biogen (BIIB) to Outperform

Jan 13, 2022 10:55AM Biogen (BIIB) Gains as CEO Hints at 'Strategic Options'

Nov 17, 2021 07:45AM Biogen's Alzheimer's drug gets negative European panel vote

Oct 7, 2021 06:11AM Ionis Pharmaceuticals (IONS) is High Risk but RBC Capital Likes the Setup Into ALS Data

Sep 22, 2021 07:07AM Biogen (BIIB) Analyst Day Offered Little Incremental Value - RBC Capital

Jun 28, 2021 05:45AM UPDATE: Biogen (BIIB) PT Lowered to $354 at RBC Capital

Jun 10, 2021 05:11PM Prothena Corp (PRTA) PT Raised to $50 at RBC Capital

Dec 1, 2020 06:58AM UPDATE: Biogen (BIIB) PT Raised to $256 at RBC Capital After SAGE Deal Call

Oct 19, 2020 06:45AM Biogen (BIIB) PT Lowered to $268 at RBC Capital After Mock Adcomm

Sep 18, 2020 11:49AM Biogen's (BIIB) Tecfidera Drop-off Will Be Larger than Expected, PT Lowered to $277 - RBC Capital

Jun 18, 2020 09:49AM Biogen (BIIB) Tecfidera Reduction Impact ~$20/Share - RBC

Jun 18, 2020 09:26AM Pre-Open Stock Movers 06/18: (ALPN) (AEMD) (ELOX) Higher; (LPTX) (QUIK) (BIIB) Lower (more...)

May 29, 2020 07:07AM Biogen (BIIB) PT Lowered to $303 at RBC Capital Ahead of District Court Rulings

Feb 5, 2020 03:26PM Biogen (BIIB) PT Raised to $321 at RBC Capital

Jan 30, 2020 01:09PM Biogen (BIIB) PT Lowered to $280 at RBC Capital

Jan 28, 2020 07:07AM RBC Capital Remains on Biogen (BIIB) Sidelines Ahead of PTAB IPR Decision

Nov 18, 2019 12:49PM Biogen (BIIB) New 'Mystery' Candidate BIIB101 Moves Into Clinic - RBC

View Older Stories